The role of clinical studies for pets with naturally occurring tumors in translational cancer research workshop summary

Traditional preclinical mouse models of cancer have been very useful for studying the biology of cancer, however they often lack key characteristics of human cancers. As a result, many novel drug candidates fail in human clinical trials despite evidence of drug efficacy in those preclinical models....

Full description

Bibliographic Details
Main Author: Nass, Sharyl J.
Corporate Authors: National Cancer Policy Forum (U.S.), National Academies of Sciences, Engineering, and Medicine (U.S.), Role of Clinical Studies for Pets with Naturally Occurring Tumors in Translational Cancer Research (Workshop) (2015, Washington, D.C.)
Other Authors: Gorby, Heather ([rapporteur])
Format: eBook
Language:English
Published: Washington, DC The National Academies Press [2015], 2015
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 03259nam a2200385 u 4500
001 EB001839901
003 EBX01000000000000001003890
005 00000000000000.0
007 tu|||||||||||||||||||||
008 180702 r ||| eng
020 |a 0309379903 
020 |a 9780309379908 
100 1 |a Nass, Sharyl J. 
245 0 0 |a The role of clinical studies for pets with naturally occurring tumors in translational cancer research  |h Elektronische Ressource  |b workshop summary  |c Sharyl J. Nass and Heather Gorby, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine 
246 3 1 |a Translational cancer research 
260 |a Washington, DC  |b The National Academies Press  |c [2015], 2015 
300 |a 1 PDF file (xx, 62 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Neoplasms / veterinary 
653 |a Translational Medical Research 
653 |a Clinical Trials as Topic 
653 |a Neoplasms / pathology 
653 |a Neoplasms / etiology 
653 |a Antineoplastic Agents / therapeutic use 
653 |a Disease Models, Animal 
700 1 |a Gorby, Heather  |e [rapporteur] 
710 2 |a National Cancer Policy Forum (U.S.) 
710 2 |a National Academies of Sciences, Engineering, and Medicine (U.S.) 
710 2 |a Role of Clinical Studies for Pets with Naturally Occurring Tumors in Translational Cancer Research (Workshop) (2015, Washington, D.C.) 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
500 |a "The National Academies of Sciences, Engineering, Medicine." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK338434  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a Traditional preclinical mouse models of cancer have been very useful for studying the biology of cancer, however they often lack key characteristics of human cancers. As a result, many novel drug candidates fail in human clinical trials despite evidence of drug efficacy in those preclinical models. Thus, researchers are seeking new approaches to augment preclinical knowledge before undertaking clinical trials for human patients. Recently, there has been renewed interest in comparative oncology - the study of naturally developing cancers in animals as models for human disease - as one way to improve cancer drug development and reduce attrition of investigational agents. Tumors that spontaneously develop in pet dogs and other companion animals as a result of normal aging share many characteristics with human cancers, such as histological appearance, tumor genetics, biological behavior, molecular targets, and therapeutic response. In June 2015 the Institute of Medicine hosted a workshop to examine the rationale and potential for integrating clinical trials for pet patients with naturally occurring cancers into translational cancer research and development. Participants discussed the research needs, strategies, and resources to support greater integration of clinical trials for pets with cancer into translational research pathways, and challenges and potential solutions for facilitating that integration. This report summarizes the presentations and discussions from the workshop